Automated description from the Alliance of Genome Resources (Release 7.1.0)
Enables cysteine-type endopeptidase inhibitor activity involved in apoptotic process. Acts upstream of or within T cell differentiation and T cell receptor signaling pathway. Predicted to be located in cytoplasm. Predicted to be active in mitochondrial outer membrane. Is expressed in several structures, including adipose tissue; craniocervical region bone; hemolymphoid system; liver; and respiratory system. Orthologous to human BCL2A1 (BCL2 related protein A1).